Jefferies analyst Matthew Taylor initiated coverage of Shoulder Innovations (SI) with a Buy rating and $19 price target The firm says the company is gaining share in the large and growing shoulder market. Shoulder Innovations’s “superior” clinical data and efficiency advantages “give it the right to win,” the analyst tells investors in a research note. Jefferies believes the company can post over 30% annual revenue growth through 2028.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SI:
- Shoulder Innovations initiated with an Overweight at Piper Sandler
- Strong Buy Rating for Shoulder Innovations, Inc. Driven by Market Leadership and High Growth Potential
- Buy Rating for Shoulder Innovations, Inc.: Strong Growth Potential in Shoulder Replacement Market
- Shoulder Innovations initiated with a Buy at Goldman Sachs